a public good project by the
Synthesis
Company
of California

© 2026

Ruxandra Ionescu | doi.page

0 works0 citations0 h-index

Ruxandra Ionescu

Carol Davila University of Medicine and Pharmacy(RO)

Publications by Year

Research Areas

Rheumatoid Arthritis Research and Therapies, Systemic Sclerosis and Related Diseases, Systemic Lupus Erythematosus Research, Spondyloarthritis Studies and Treatments, Monoclonal and Polyclonal Antibodies Research

Most-Cited Works

→ Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA Study(2010)284 cited
→ “To Be or Not To Be,” Ten Years After: Evidence for Mixed Connective Tissue Disease as a Distinct Entity(2012)160 cited
→ Development of patient-centred standards of care for osteoarthritis in Europe: the eumusc.net-project(2014)122 cited
→ Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries(2011)73 cited
→ Treat-to-target strategy for knee osteoarthritis. International technical expert panel consensus and good clinical practice statements(2019)56 cited
→ Roles of CD147 on T lymphocytes activation and MMP‐9 secretion in Systemic Lupus Erythematosus(2007)44 cited

→ Monitoring Drug and Antidrug Levels: A Rational Approach in Rheumatoid Arthritis Patients Treated with Biologic Agents Who Experience Inadequate Response While Being on a Stable Biologic Treatment(2014)

41 cited

→ Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort(2022)38 cited

→ The challenge of the definition of early symptomatic knee osteoarthritis: a proposal of criteria and red flags from an international initiative promoted by the Italian Society for Rheumatology(2017)37 cited

→ Efficacy and safety of original and biosimilar etanercept (SB4) in active rheumatoid arthritis – A comparison in a real-world national cohort(2019)32 cited